Oil slips as COVID-19 and demand concerns weigh ahead of supply report    Egypt FM, EU Special Representative discuss efforts to revive Israeli-Palestinian peace process    Egypt's stocks end higher, benchmark EGX 30 gains 0.45% on Wednesday    UNCTAD: Egypt remains Africa's top destination for FDI despite pandemic    Egypt contracts French RATP to manage Cairo's new electric train line    Egypt's TAQA Arabia IPO may be delayed to beyond Q1-2022    Tunisian press syndicate criticise police over night arrest    Mali army and French forces kill 100 extremists this month    Arsenal signs midfielder Odegaard on loan from Real Madrid    EU meeting with Astra on vaccine supplies canceled after firm pulls out: EU official    Asian Champions League holders Ulsan to face debutants in group phase    Tennis: Nadal, Serena support strict COVID-19 protocols in Australia    Biden says he's 'bringing back the pros' for virus briefings    Cabinet under fire    Egypt reports 643 new coronavirus cases, 55 deaths on Tuesday    Rana Haggag's jazz concert at Room Art Space & Café is a must go    Scheherazade retold    Taming the ogre    Cabinet building    Egypt announces resumption of maritime navigation with Qatar    Egyptian FM to deliver statement on foreign policy before parliament Tuesday    Egypt confirms 669 new coronavirus cases, 53 deaths on Monday    Minister outlines Egypt's efforts to fulfill international environmental commitments    Egypt launches website for vaccination registration    Egypt joins Netherlands, Malawi in supporting UK-led scheme to fight against climate change    New daily Coronavirus cases continued to fall over the weekend    BREAKING: Egypt resumes diplomatic relations with Qatar ending 4-year boycott    Egypt eyes gradual return for tourism after revenues fall to $4 bln in 2020    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Coronavirus strikes Egypt's youth team as 17 players, coach test positive    Nassef Sawiris plans to up his stake in owner of New York Knicks, Rangers    Cairo International Book Fair suspended for five months over coronavirus concerns    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Type O blood linked to lower COVID risk, taking Vitamin D unlikely to help
Published in Ahram Online on 29 - 11 - 2020


Certain blood groups less likely to get COVID-19
A large study adds to evidence that people with type O or Rh−negative blood may be at slightly lower risk from the new coronavirus. Among 225,556 Canadians who were tested for the virus, the risk for a COVID-19 diagnosis was 12% lower and the risk for severe COVID-19 or death was 13% lower in people with blood group O versus those with A, AB, or B, researchers reported on Tuesday in Annals of Internal Medicine. People in any blood group who were Rh-negative were also somewhat protected, especially if they had O-negative blood. People in these blood type groups may have developed antibodies that can recognize some aspect of the new virus, coauthor Dr. Joel Ray of St. Michael's Hospital in Toronto told Reuters. "Our next study will specifically look at such antibodies, and whether they explain the protective effect," Ray said. Whether or how this information might influence COVID-19 prevention or treatment is still unclear.
Vitamin D fails to help in severe COVID-19 cases
Low levels of vitamin D have been linked to higher risk for severe COVID-19, but high vitamin D levels do not fix the problem. Increasing vitamin D levels in critically ill patients did not shorten their hospital stay or lower their odds of being moved to intensive care, needing mechanical ventilation, or dying, doctors in Brazil found. They randomly gave 240 patients hospitalized with severe COVID-19 either a single high dose of vitamin D3 or a placebo. Only 6.7% of patients in the vitamin D group had "deficient" levels of the nutrient, compared to 51.5% of patients in the placebo group, but there was no difference in the outcomes, according to a paper posted on medRxiv ahead of peer review. The same was true when the researchers focused on the 116 patients with vitamin D deficiency before the treatment. The authors say theirs is the first randomized trial of its kind to show that vitamin D supplementation "is ineffective to improve hospital length of stay or any other clinical outcomes among hospitalized patients with severe COVID-19."
Triggers of COVID-19 “cytokine storm” identified
A form of inflammatory cell death called panoptosis triggers the storm of cytokines, or inflammatory proteins, that causes critical illness in COVID-19, researchers say. During panoptosis, "cells spew out their contents instead of neatly packaging them away" as happens during routine cell death, Thirumala-Devi Kanneganti of St. Jude Children's Research Hospital told Reuters. Neighboring cells see the debris, including cytokines, as a sign of danger, and respond by secreting more cytokines, allowing the cytokine storm to build, said Kanneganti. Her team identified a synergy between two cytokines, TNF-alpha and IFN-gamma, as the cause of panoptosis in COVID-19. Mice given TNF-alpha and IFN-gamma developed the symptoms and organ damage of COVID-19 and died rapidly, Kanneganti said. Treatment with antibodies that neutralize these two cytokines protected the mice from death, not just from COVID-19 but also from other life-threatening illnesses involving cytokine storms, such as sepsis, her team reported in Cell. Trials are needed to test these treatments in humans, Kanneganti said.


Clic here to read the story from its source.